AAAAAA
Results: 1-25/61
Authors:
Yoo, BC
Cairns, N
Fountoulakis, M
Lubec, G
Citation: Bc. Yoo et al., Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease, DEMENT G C, 12(3), 2001, pp. 219-225
Authors:
Linthicum, DS
Patel, J
Cairns, N
Citation: Ds. Linthicum et al., Antibody-based fluorescence polarization assay to screen combinatorial libraries for sweet taste compounds, COMB CHEM H, 4(5), 2001, pp. 431-438
Authors:
Gulesserian, T
Seidl, R
Hardmeier, R
Cairns, N
Lubec, G
Citation: T. Gulesserian et al., Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down Syndrome, J INVES MED, 49(1), 2001, pp. 41-46
Authors:
Murphy, T
Yip, A
Brayne, C
Easton, D
Evans, JG
Xuereb, J
Cairns, N
Esiri, MM
Rubinsztein, DC
Citation: T. Murphy et al., The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer's disease, NEUROREPORT, 12(3), 2001, pp. 631-634
Authors:
Bajo, M
Yoo, BC
Cairns, N
Gratzer, M
Lubec, G
Citation: M. Bajo et al., Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease, AMINO ACIDS, 21(3), 2001, pp. 293-301
Authors:
Seidl, R
Bidmon, B
Bajo, M
Yoo, BC
Cairns, N
LaCasse, EC
Lubec, G
Citation: R. Seidl et al., Evidence for apoptosis in the fetal Down syndrome brain, J CHILD NEU, 16(6), 2001, pp. 438-442
Authors:
Lambri, M
Djurovic, V
Kibble, M
Cairns, N
Al-Sarraj, S
Citation: M. Lambri et al., Specificity and sensitivity of beta APP in head injury, CLIN NEUR, 20(6), 2001, pp. 263-271
Authors:
Engidawork, E
Gulesserian, T
Seidl, R
Cairns, N
Lubec, G
Citation: E. Engidawork et al., Expression of apoptosis related proteins in brains of patients with Alzheimer's disease, NEUROSCI L, 303(2), 2001, pp. 79-82
Authors:
Kim, SH
Cairns, N
Fountoulakisc, M
Lubec, G
Citation: Sh. Kim et al., Decreased brain histamine-releasing factor protein in patients with Down syndrome and Alzheimer's disease, NEUROSCI L, 300(1), 2001, pp. 41-44
Authors:
Gulesserian, T
Engidawork, E
Yoo, BC
Cairns, N
Lubec, G
Citation: T. Gulesserian et al., Alteration of caspases and other apoptosis regulatory proteins in Down syndrome, J NEUR TR-S, (61), 2001, pp. 163-179
Authors:
Engidawork, E
Gulesserian, T
Seidl, R
Cairns, N
Lubec, G
Citation: E. Engidawork et al., Expression of apoptosis related proteins: RAIDD, ZIP kinase, Bim/BOD, p21,Bax, Bcl-2 and NF-kappa B in brains of patients with Down syndrome, J NEUR TR-S, (61), 2001, pp. 181-192
Authors:
Balcz, B
Kirchner, L
Cairns, N
Fountoulakis, M
Lubec, G
Citation: B. Balcz et al., Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down Syndrome and Alzheimer's disease, J NEUR TR-S, (61), 2001, pp. 193-201
Authors:
Engidawork, E
Gulesserian, T
Balic, N
Cairns, N
Lubec, G
Citation: E. Engidawork et al., Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's disease, J NEUR TR-S, (61), 2001, pp. 211-222
Authors:
Kim, SH
Fountoulakis, M
Cairns, N
Lubec, G
Citation: Sh. Kim et al., Protein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down Syndrome, J NEUR TR-S, (61), 2001, pp. 223-235
Authors:
Seidl, R
Cairns, N
Lubec, G
Citation: R. Seidl et al., The brain in Down syndrome, J NEUR TR-S, (61), 2001, pp. 247-261
Authors:
Kim, SH
Nairn, AC
Cairns, N
Lubec, G
Citation: Sh. Kim et al., Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease, J NEUR TR-S, (61), 2001, pp. 263-272
Authors:
Vlkolinsky, R
Cairns, N
Fountoulakis, M
Lubec, G
Citation: R. Vlkolinsky et al., Decreased brain levels of 2 ',3 '-cyclic nucleotide-3 '-phosphodiesterase in Down syndrome and Alzheimer's disease, NEUROBIOL A, 22(4), 2001, pp. 547-553
Authors:
Yoo, BC
Vlkolinsky, R
Engidawork, E
Cairns, N
Fountoulakis, M
Lubec, G
Citation: Bc. Yoo et al., Differential expression of molecular chaperones in brain of patients with Down syndrome, ELECTROPHOR, 22(6), 2001, pp. 1233-1241
Authors:
Cheon, MS
Bajo, M
Gulesserian, T
Cairns, N
Lubec, G
Citation: Ms. Cheon et al., Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease, ELECTROPHOR, 22(3), 2001, pp. 445-448
Authors:
Seidl, R
Labudova, O
Henriksson, EW
Craft, J
Turhani-Schatzmann, D
Achsel, T
Bidmon, B
Pruijn, GJM
Cairns, N
Lubec, G
Citation: R. Seidl et al., Deficient brain snRNP70K in patients with Down syndrome, ELECTROPHOR, 22(1), 2001, pp. 43-48
Authors:
Yoo, BC
Fountoulakis, M
Cairns, N
Lubec, G
Citation: Bc. Yoo et al., Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down Syndrome, ELECTROPHOR, 22(1), 2001, pp. 172-179
Authors:
Seidl, R
Cairns, N
Singewald, N
Kaehler, ST
Lubec, G
Citation: R. Seidl et al., Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology, N-S ARCH PH, 363(2), 2001, pp. 139-145
Authors:
Schuller, E
Gulesserian, T
Seidl, R
Cairns, N
Lubec, G
Citation: E. Schuller et al., Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate beta 1 tubulin is decreased in Alzheimer's disease, LIFE SCI, 69(3), 2001, pp. 263-270
Authors:
Kim, SH
Vlkolinsky, R
Cairns, N
Fountoulakis, M
Lubec, G
Citation: Sh. Kim et al., The reduction of NADH Ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease, LIFE SCI, 68(24), 2001, pp. 2741-2750
Authors:
Krapfenbauer, K
Yoo, BC
Kim, SH
Cairns, N
Lubec, G
Citation: K. Krapfenbauer et al., Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome, LIFE SCI, 68(18), 2001, pp. 2169-2179